Cannabidiol for early psychosis not fully improved by clozapine
Treatments studied
Part of Mental health clinical trials.
This trial tests whether adding a cannabis-based medicine called cannabidiol (CBD) to clozapine helps people with early psychosis who still have symptoms. It may improve your symptoms and overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 16 and 50 years old
- You must have been taking clozapine for at least 8 weeks at a certain dose
- You must have been on antipsychotic medication for less than 10 years
- You must have symptoms like delusions, hallucinations, or disorganized thinking
- You must be willing to use effective birth control if you could become pregnant
- You must be able to attend all trial visits and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a CBD medication to your current antipsychotic can improve symptoms in people with schizophrenia or related disorders who started treatment recently but aren't fully better yet.
This trial tests a special clinic that helps people with a first episode of psychosis cut down or stop using cannabis. The clinic provides talking support and practical help, and the goal is to improve your mental health and quality of life.
This Phase 3 trial tests whether taking cannabidiol (CBD) can reduce symptoms when added to standard care for early psychosis (like first-episode psychosis or attenuated psychosis). It may help some people have fewer troubling thoughts or perceptions over time.
This study tests whether a medication called cannabidiol (a non-intoxicating compound from cannabis) can help reduce symptoms and prevent progression in young people at clinical high risk for psychosis. Participants will receive either the study drug or a placebo (a pill with no active ingredient) and will be followed to see how they respond.
This trial tests whether cannabidiol (CBD) can reduce symptoms of bipolar depression. You may be eligible if you have bipolar I or II and a current depressive episode while staying on approved mood-stabilizing or antipsychotic medication.
This study tests whether cannabidiol (CBD) can help young adults who use cannabis heavily but aren't looking to quit. You'll take a CBD pill and see if it changes your cannabis use or related symptoms.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.